Search results
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma...
Benzinga via Yahoo Finance· 3 days agoMonday, Merck & Co Inc (NYSE:MRK) announced the discontinuation of the vibostolimab and...
Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study
Morningstar· 3 days agoMerck & Co. has ended part of a late-stage study of a co-formulation of its blockbuster cancer drug Keytruda in certain skin-cancer patients because the ...
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 7 days agoMerck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 2 days agoWith Merck’s growth largely depending on Keytruda, the recent pipeline setbacks do not bode well for...
Tri-Cities doctor fined after prescribing ivermectin for COVID. 2nd physician charged
Tri-City Herald McClatchy via AOL· 5 days agoOne doctor joined in a lawsuit against the Washington Medical Commission with the help of the Silent...
Organon & Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024
GuruFocus.com via Yahoo Finance· 16 hours agoThe top holdings included 12.56% in Assured Guaranty Ltd (NYSE:AGO), 12.01% in Merck & Co Inc...
Lilly's Once-Weekly Insulin Top-Line Results Show Benefit
Medscape· 7 hours agoEli Lilly has announced positive phase 3 topline results for its once-weekly insulin efsitora alfa...
Merck Expands Access to High-Quality Maternal Care for More
3BL CSRwire· 3 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global maternal health initiative, has reached more than 30 million ...
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
Reuters· 2 days ago, opens new tab said on Tuesday the U.S. Food and Drug Administration (FDA) has declined to approve...
Merck stops skin cancer combination therapy testing in late-stage study
Reuters· 3 days ago, opens new tab has discontinued testing a combination of an experimental antibody-based drug and...